Arkansas Children's Hospital Research Institute
archildrens.orgTotal trials
120
Active
35
Phase 3
0
Total enrollment
18,859
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Elexacaftor / Ivacaftor / Tezacaftor | — | — | — | — | — | 1 | |
| Ketorolac | — | — | — | — | — | 1 |
Next readouts
- 2025-05
- 2030-12
Top conditions
- Healthy32
- Asthma11
- Insulin Resistance5
- Obesity4
- Pregnancy3
- Eosinophilic Esophagitis3
- Physical Activities2
- Obese2
Frequently asked questions about Arkansas Children's Hospital Research Institute
- How many clinical trials does Arkansas Children's Hospital Research Institute have on ClinicalTrials.gov?
- Arkansas Children's Hospital Research Institute is listed as the lead sponsor on 120 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Arkansas Children's Hospital Research Institute's trials are in Phase 3?
- 0 of Arkansas Children's Hospital Research Institute's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Arkansas Children's Hospital Research Institute focus on?
- Arkansas Children's Hospital Research Institute's most-studied conditions on ClinicalTrials.gov are Healthy, Asthma, Insulin Resistance, Obesity, Pregnancy.
- When are Arkansas Children's Hospital Research Institute's next clinical trial readouts?
- Arkansas Children's Hospital Research Institute has 2 upcoming primary-completion readouts tracked here; the soonest is “Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement”, expected around 2025-05.